We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Poolbeg Pharma Plc | LSE:POLB | London | Ordinary Share | GB00BKPG7Z60 | ORD 0.02P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 2.30 | 17.23% | 15.65 | 15.50 | 15.80 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 15.70 | 13.35 | 13.35 | 7,541,591 | 14:35:14 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 0 | -4.69M | -0.0094 | -16.38 | 77M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 01/5/2024 | 16:39 | ALNC |  Poolbeg Pharma celebrates full patent approval for Immunomodulator II |
| 01/5/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Significant POLB 001 Patent Granted in USA |
| 30/4/2024 | 16:30 | ALNC | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down |
| 30/4/2024 | 07:02 | UK RNS | Poolbeg Pharma PLC Appointment of Joint Broker |
| 30/4/2024 | 07:01 | UK RNS | Poolbeg Pharma PLC Option Agreement to Acquire Orphan Drug Candidate |
| 30/4/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Results for the year ended 31 December 2023 |
| 29/4/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC TR-1: Notification of major holdings |
| 20/3/2024 | 16:18 | ALNC | EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake |
| 20/3/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC POLB 001 US Patent Update |
| 22/2/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Director/PDMR Shareholding |
1 Year Poolbeg Pharma Chart |
Intraday Poolbeg Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
